Your browser doesn't support javascript.
loading
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials.
Fuhlbrigge, Anne L; Bengtsson, Thomas; Peterson, Stefan; Jauhiainen, Alexandra; Eriksson, Göran; Da Silva, Carla A; Johnson, Anthony; Sethi, Tariq; Locantore, Nicholas; Tal-Singer, Ruth; Fagerås, Malin.
Afiliação
  • Fuhlbrigge AL; Pulmonary Sciences and Critical Care, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA.
  • Bengtsson T; StatMind Statistical and Mathematical Modelling, Innovation and Design AB, Lund, Sweden.
  • Peterson S; StatMind Statistical and Mathematical Modelling, Innovation and Design AB, Lund, Sweden.
  • Jauhiainen A; AstraZeneca, Research and Development, Early Clinical Development, Gothenburg, Sweden.
  • Eriksson G; Department of Respiratory Medicine and Allergology, Lund University Hospital, Lund, Sweden.
  • Da Silva CA; AstraZeneca, Research and Development, Early Clinical Development, Gothenburg, Sweden.
  • Johnson A; AstraZeneca, Research and Development, Early Clinical Development, Gothenburg, Sweden.
  • Sethi T; AstraZeneca, Research and Development, Early Clinical Development, Gothenburg, Sweden.
  • Locantore N; GlaxoSmithKline Research and Development, King of Prussia, PA, USA.
  • Tal-Singer R; GlaxoSmithKline Research and Development, King of Prussia, PA, USA.
  • Fagerås M; Global Product and Portfolio Strategy, Global Medical Affairs, Gothenburg, Sweden. Electronic address: malin.fageras@astrazeneca.com.
Lancet Respir Med ; 5(7): 577-590, 2017 07.
Article em En | MEDLINE | ID: mdl-28583396

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Volume Expiratório Forçado / Antiasmáticos / Determinação de Ponto Final Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Volume Expiratório Forçado / Antiasmáticos / Determinação de Ponto Final Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos